Search Results 21-30 of 17347 for glomerulonephritis.
The purpose of this study is to determine if Obinutuzumab is effective and safe in treating patients with fibrillary glomerulonephritis. Participation ...
The purpose of this study is to assess the effectiveness of daratumumab SC in treating patients with monoclonal immunoglobulin deposits (PGNMID) by assessing ...
Glomerulonephritis (inflammation in the kidney cells that filter waste from the blood); High blood pressure (hypertension) · IgA nephropathy (Berger disease) ...
Glomerulonephritis disorders are the third most common type of kidney disease. It is thought that the condition is often caused by immune system dysfunction, ...
Elevated blood pressure · End-stage kidney disease; Fibrillary glomerulonephritis ... Immunotactoid glomerulonephritis; Inherited cystic kidney disorders ...
Will use of Rituximab reduce proteinuria over a 12 month period and will there be preservation of kidney function with the use of this study drug? Participation ...
Pediatric nephrologists diagnose and treat children with the following disease and conditions: Acute glomerulonephritis; Acute kidney failure; Alport syndrome ...
People come to Mayo Clinic for help with many kinds of kidney and blood pressure conditions, such as: Glomerulonephritis. Polycystic kidney disease. Hard-to- ...
Diseases and conditions that cause chronic kidney disease include: Type 1 or type 2 diabetes; High blood pressure; Glomerulonephritis (gloe-mer-u-low-nuh-FRY- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.